Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01967433 · ClinicalTrials.gov registry record · Phase 4

Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids

A Phase 4 study, sponsored by University of Oklahoma.

Completed
Registry status
Phase 4
Development phase
120
Enrollment target

NCT01967433 is a Phase 4 study that has completed, run by University of Oklahoma. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01967433, a Phase 4 study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
Phase 4
Development phase
120 participants
Enrollment target

Study Summary

To access the efficacy of adding diphenhydramine as adjunct to improve sedation and to reduce the amount of standard sedatives used during colonoscopy in patients on chronic opioids.

Interventions

  • DRUG Placebo
  • DRUG Diphenhydramine

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2013-12
Est. Completion 2018-07
Phase Phase 4

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT01967433

The ClinicalTrials.gov registry entry for NCT01967433 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01967433 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01967433 about?

NCT01967433 is a clinical study titled "Diphenhydramine as an Adjunctive Sedative in Patients on Chronic Opioids". To access the efficacy of adding diphenhydramine as adjunct to improve sedation and to reduce the amount of standard sedatives used during colonoscopy in patients on chronic opioids.

What is the current status of trial NCT01967433?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2013-12. Estimated completion is 2018-07.

What interventions are being tested in trial NCT01967433?

The interventions under investigation include: Placebo (DRUG), Diphenhydramine (DRUG).

Who is sponsoring clinical trial NCT01967433?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.